Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: A prospective open trial

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 27, Issue 3, 2003, Pages 373-379

  Tang, Wai Kwong ^a   Ungvari, Gabor S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Clozapine; Electroconvulsive therapy; Schizophrenia; Treatment resistance

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG POTENTIATION; ELECTROCONVULSIVE THERAPY; EVALUATION; FEMALE; HAMILTON SCALE; HONG KONG; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; OCCUPATIONAL THERAPIST; PROSPECTIVE STUDY; RATING SCALE; REHABILITATION; SCHIZOPHRENIA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0037402539     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(02)00354-8     Document Type: Article

References (46)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994;American Psychiatric Association, Washington, DC.
2. Andreasen N.C. The Scale for Assessment of Negative Symptoms (SANS). Br. J. Psychiatry. 155(Suppl. 7):1989;S53-S58.
3. Baker A.A., Bird G., Lavin N.I., Thorpe J.G. ECT in schizophrenia. J. Ment. Sci. 106:1960;1506-1511.
4. Barnes T.R.E., McEvedy C.J.B. Pharmacological treatment strategies in the non-responsive schizophrenic patient. Int. Clin. Psychopharmacol. 11(Suppl. 2):1996;S67-S71.
5. Benatov R., Sirota P., Sorin M. Neuroleptic-resistant schizophrenia treated with clozapine and ECT. J. ECT. 1:1996;117-121.
6. Bhatia S.C., Bhatia S.K., Gupta S.G. Concurrent administration of clozapine and ECT: a successful therapeutic strategy for a patient with treatment-resistant schizophrenia. J. ECT. 14:1998;280-283.
7. Breier A., Buchanan R.W., Irish D., Carpenter W.T. Jr. Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. Hosp. Community Psychiatry. 44:1993;1145-1149.
8. Chanpattana W. Maintenance ECT in schizophrenia: a pilot study. J. Med. Assoc. Thail. 81:1998;17-24.
9. Chanpattana W., Chakrabhand M.L., Sackeim H.A., Kitaroonchai W., Kongsakon R., Techakasem P., Buppanharun W., Tuntirungsee Y., Kirdcharoen N. Continuation ECT in treatment-resistant schizophrenia: a controlled study. J. ECT. 15:1999;178-192.
10. Conley R.R. Optimizing treatment with clozapine. J. Clin. Psychiatry. 59(Suppl. 3):1998;S44-S48.
11. Danziger L., Kendwall J.A. Prediction of the immediate outcome of shock therapy in dementia praecox. Dis. Nerv. Syst. 7:1946;229-303.
12. Endicott J., Spitzer R., Fliess J. The Global Assessment Scale. Arch. Gen. Psychiatry. 33:1976;766-771.
13. Essock S.M., Hargreaves W.A., Dohm F., Goethe J., Carver L., Hipshman L. Clozapine eligibility among state hospital patients. Schizophr. Bull. 22:1996;15-25.
14. Fink M. Is ECT a useful therapy in schizophrenia? Brady J.P., Brodie H.K.H. Controversy in Psychiatry. 1978;183-193 Saunders, Philadelphia, PA.
15. Fink M., Sackeim H.A. Convulsive therapy in schizophrenia. Schizophr. Bull. 22:1996;27-39.
16. Flynn S.W., MacEwan G.W., Altman S., Kopala L.C., Fredrikson D.H., Smith G.N., Honer W.G. An open comparison of clozapine and risperidone in treatment-resistant schizophrenia. Pharmacopsychiatry. 31:1998;25-29.
17. Friedel R.O. The combined use of neuroleptic and ECT in drug resistant schizophrenic patients. Psychopharmacol. Bull. 22:1986;928-930.
18. Green A.I., Zalma A., Berman I., Durand C.J., Salzman C. Clozapine following ECT: a two-step treatment. J. Clin. Psychiatry. 55:1996;388-390.
19. Gujavarty K., Greenberg L.B., Fink M. ECT and neuroleptic medication in therapy-resistant positive-symptoms psychosis. J. ECT. 3:1987;185-195.
20. Guy W. ECDEU Assessment for Psychopharmacology. 1976;534-537 HEW Public Health Service, Washington, DC.
21. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6:1967;278-296.
22. Hoflich G., Kasper S., Burghof K., Scholl H., Möller H. Maintenance ECT for treatment of therapy-resistant paranoid schizophrenia and Parkinson's disease. Biol. Psychiatry. 37:1995;892-894.
23. Honigfeld G., Gillis R.D., Klett C.J. NOSIE-30: a treatment-sensitive ward behaviour scale. Psychol. Rep. 19:1966;180-182.
24. James D.V., Gray N.S. Elective combined electroconvulsive and clozapine therapy. Int. Clin. Psychopharmacol. 14:1999;69-72.
25. Juarez-Reyes M.G., Shumway M., Bacchetti P., Hansen M.S., Hargreaves W.A. Effects of stringent criteria on eligibility for clozapine among public mental health clients. Psychiatr. Serv. 46:1995;801-806.
26. Kales H. Combined electroconvulsive therapy and clozapine in schizophrenia. Biol. Psychiatry. 37:1995;678.
27. Kales H.C., Dequardo J.R., Tandon R. Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 23:1999;547-556.
28. Kane J.M., Honigfeld G., Singer J., Meltzer H.Y. Clozapine for the treatment-resistant schizophrenic. Arch. Gen. Psychiatry. 45:1988;789-796.
29. Kendell R.E. The present status of electroconvulsive therapy. Br. J. Psychiatry. 139:1981;265-283.
30. Kino F.F., Thorpe F.T. Electrical convulsion therapy in 500 selected psychotics. Convuls. Ther. 12:1946;138-145.
31. Klapheke M.M. Clozapine, ECT, and schizoaffective disorder, bipolar type. J. ECT. 7:1991;36-39.
32. Kuipers E. The management of difficult to treat patients with schizophrenia, using non-drug therapies. Br. J. Psychiatry. 169(Suppl. 31):1996;S41-S51.
33. Kupchik M., Spivak B., Mester R., Reznik I., Gonen N., Weizman A., Kotler M. Combined electroconvulsive-clozapine therapy. Clin. Neuropharmacol. 23:2000;14-16.
34. Lohr W.D. Maintenance electroconvulsive therapy in schizophrenia. J. Clin. Psychiatry. 55:1994;217-218.
35. Meltzer H.Y. Treatment of the neuroleptic-nonresponsive schizophrenic patient. Schizophr. Bull. 18:1992;515-542.
36. Overall J.E., Klett C.J. Applied Multivariate Analysis. 1972;3-13 McGraw-Hill, New York.
37. Rahman R. Review of treatment of 176 schizophrenic patients in the mental hospital Pabna. Br. J. Psychiatry. 114:1968;775-777.
38. Royal College of Psychiatrists The ECT handbook. Freeman C.P. The Second Report of the Royal College of Psychiatrist's Special Committee on ECT. 1995;Royal College of Psychiatrists, London.
39. Sajatovic M., Meltzer H. The effect of short term electroconvulsive treatment plus neuroleptics. J. ECT. 9:1993;167-175.
40. Sharif Z.A. Efficacy and safety of combining ECT and clozapine in patients with treatment refractory schizophrenia. Schizophr. Res. 29:1998;163.
41. Shear M.K. Case conferences from Cornell. Psychiatr. Q. 50:1978;299-306.
42. Tang W.K., Ungvari G.S. Electroconvulsive therapy in rehabilitation: the Hong Kong experience. Psychiatr. Serv. 52:2001;303-306.
43. Ucok A. Maintenance ECT in a patient with catatonic schizophrenia and tardive dyskinesia. J. ECT. 12:1996;108-112.
44. Ungvari G.S., Chiu H.F.K., Lam L.C.W., Pang A.H.T., Chung D.W., Li S.W., Chiu S.N., Lum F.C., Leung T. Gradual withdrawal of long-term anticholinergic antiparkinson medication in Chinese patients with chronic schizophrenia. J. Clin. Psychopharmacol. 19:1999;141-148.
45. Zheng Y., Zhao J., Philips M., Dai C., Zheng H. Validity and reliability of the Chinese Hamilton Depression Rating Scale. Br. J. Psychiatry. 152:1988;660-664.
46. Zito J.M., Volavka J., Craig T.J., Czobor P., Banks S., Vitrai J. Pharmacoepidemiology of clozapine in 202 inpatients with schizophrenia. Ann. Pharmacother. 27:1993;1262-1269.